The firm is interested in companies that drive values in private and public companies through operational and strategic directions such as academic science, clinical and commercial strategy, and other things. Arix Bioscience plc is interested in companies that develop biotechnologies, immune system treatments for cancer, therapeutics, and pharmaceuticals.
Funding Rounds Participated In
- Autolus TherapeuticsAutolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
- Artios PharmaArtios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
- Nested (company)